US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MBX Biosciences

7.62

+0.11001.46%

Post-market: 7.620.00000.00%16:20 EDT

Volume:218.71K

Turnover:1.65M

Market Cap:254.69M

PE:-1.31

High:7.85

Open:7.48

Low:7.09

Close:7.51

Loading ...

Overview Company News Filings

Nasdaq Net Change Percentage Gainers & Losers

Microbix Biosystems: Strong Q4 Performance and Promising Growth Prospects

Microbix Biosystems Reports Record Revenue Growth

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

My Foodie Box Pursues ASX Reinstatement with New Funding

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism

My Foodie Box Limited Reports Drastic Loss Reduction

MBX Biosciences completes last visit in Phase 1 MBX 1416 trial in hypoglycemia

BRIEF-MBX Biosciences Announces Last Subject Last Visit In Phase 1 Trial

Mbx Biosciences Announces Last Subject Last Visit in Phase 1 Trial of Mbx 1416 for the Treatment of Post-Bariatric Hypoglycemia

THOMSON REUTERS

Mbx Biosciences : Look Forward to Sharing Full-Topline Results of Mbx 1416 Program in Early January 2025

THOMSON REUTERS

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

Microbix Enhances HPV Testing with New Validation

MBX Biosciences Reports Q3 2024 Financial Progress

MBX Biosciences Q3 EPS $(2.78) Up From $(9.40) YoY

Mbx Biosciences: Q3 Shr Loss $2.78

THOMSON REUTERS

Mbx Biosciences: Strong Cash Position, With $277.1 Mln Expected to Support Operations Into Mid-2027

THOMSON REUTERS

MBX Biosciences to Participate in Upcoming November Investor Conferences

Opening Day: Another trio of biotech IPOs make Friday debut

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MBX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBX\",,,,,undefined,":{"symbol":"MBX","market":"US","secType":"STK","nameCN":"MBX Biosciences","latestPrice":7.62,"timestamp":1744920000000,"preClose":7.51,"halted":0,"volume":218710,"hourTrading":{"tag":"盘后","latestPrice":7.62,"preClose":7.62,"latestTime":"16:20 EDT","volume":1183,"amount":9014.460000000001,"timestamp":1744921200676},"delay":0,"floatShares":13610296,"shares":33424371,"eps":-5.818121,"marketStatus":"Post-Mkt","change":0.11,"latestTime":"04-17 19:12:06 EDT","open":7.48,"high":7.85,"low":7.09,"amount":1652972.4193,"amplitude":0.101198,"askPrice":7.62,"askSize":10,"bidPrice":7.57,"bidSize":47,"shortable":3,"etf":0,"ttmEps":-5.818121,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1744934400000},"marketStatusCode":4,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":7.51,"preHourTrading":{"tag":"盘前","latestPrice":7.2,"preClose":7.51,"latestTime":"04:38 EDT","volume":4,"amount":30.51,"timestamp":1744879119840},"postHourTrading":{"tag":"盘后","latestPrice":7.62,"preClose":7.62,"latestTime":"16:20 EDT","volume":1183,"amount":9014.460000000001,"timestamp":1744921200676},"volumeRatio":0.393485,"impliedVol":0.2302,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBX\",,,,,undefined,":{"symbol":"MBX","floatShares":13610296,"roa":"-24.17%","roe":"-36.71%","lyrEps":-5.818121,"volumeRatio":0.393485,"shares":33424371,"dividePrice":0,"high":7.85,"amplitude":0.101198,"preClose":7.51,"low":7.09,"week52Low":4.8069,"pbRate":"0.99","week52High":27.5,"institutionHeld":0,"latestPrice":7.62,"committee":0.649123,"eps":-5.818121,"divideRate":0,"volume":218710,"delay":0,"ttmEps":-5.818121,"open":7.48,"prevYearClose":18.43,"prevWeekClose":7.41,"prevMonthClose":7.38,"prevQuarterClose":7.38,"fiveDayClose":6.27,"twentyDayClose":7.97,"sixtyDayClose":10.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495504527","title":"Nasdaq Net Change Percentage Gainers & Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2495504527","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495504527?lang=en_us&edition=fundamental","pubTime":"2024-12-31 06:43","pubTimestamp":1735598580,"startTime":"0","endTime":"0","summary":"Copyright (c) 2024 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","LU2095319765.USD","LU2210150020.SGD",".IXIC","MBX","MNQmain","QID","NDAQ","BK4585","QLD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4112","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","USAW.SI","SQQQ","PSQ","NQmain","IE00BGHQF748.EUR","BK4007","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2493249685","title":"Microbix Biosystems: Strong Q4 Performance and Promising Growth Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2493249685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493249685?lang=en_us&edition=fundamental","pubTime":"2024-12-22 21:05","pubTimestamp":1734872711,"startTime":"0","endTime":"0","summary":"Bloom Burton analyst David Martin PhD maintained a Buy rating on Microbix Biosystms (MBX – Research Report) on December 20 and set a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/microbix-biosystems-strong-q4-performance-and-promising-growth-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/microbix-biosystems-strong-q4-performance-and-promising-growth-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BK4007"],"gpt_icon":0},{"id":"2492122238","title":"Microbix Biosystems Reports Record Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2492122238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492122238?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:44","pubTimestamp":1734612284,"startTime":"0","endTime":"0","summary":"Microbix Biosystms (TSE:MBX) has released an update. Microbix Biosystems Inc. has achieved record revenues of $25.4 million for fiscal year 2024, d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microbix-biosystems-reports-record-revenue-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microbix-biosystems-reports-record-revenue-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BK4007"],"gpt_icon":0},{"id":"2492183811","title":"MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492183811","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492183811?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:00","pubTimestamp":1734526800,"startTime":"0","endTime":"0","summary":"CARMEL, Ind., Dec.  18, 2024  (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/18/2999007/0/en/MBX-Biosciences-to-Participate-in-43rd-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU0106831901.USD","LU0795875086.SGD","BK4534","HP","LU0320765646.SGD","BK4581","LU0158827948.USD","LU2357305700.SGD","LU2028103732.USD","BK4504","LU1074936037.SGD","LU2111349929.HKD","LU2271345857.HKD","IE00BKVL7J92.USD","LU0912757837.SGD","BK4585","LU2089284900.SGD","LU1720051017.SGD","LU0971096721.USD","LU1989772840.SGD","LU2023251221.USD","MBX","LU1548497426.USD","LU0225283273.USD","BK4516","LU0267386448.USD","LU1989772923.USD","IE00BZ1G4Q59.USD","LU1363072403.SGD","BK4007","LU1162221912.USD","LU0314104364.USD","LU2089283258.USD","PBH","HCSG","BK4137","BK4092","LU0006306889.USD","LU1720051108.HKD","LU0158827781.USD","LU0795875169.SGD","LU2347655156.SGD","LU1732799900.SGD","LU0098860793.USD","BK4127","LU1668664300.SGD","BK4588","LU1732800096.USD"],"gpt_icon":0},{"id":"2488157442","title":"My Foodie Box Pursues ASX Reinstatement with New Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2488157442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488157442?lang=en_us&edition=fundamental","pubTime":"2024-12-04 17:23","pubTimestamp":1733304202,"startTime":"0","endTime":"0","summary":"My Foodie Box Limited (AU:MBX) has released an update. My Foodie Box Limited is actively working towards reinstatement on the ASX by securing up to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/my-foodie-box-pursues-asx-reinstatement-with-new-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/my-foodie-box-pursues-asx-reinstatement-with-new-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BOX","LU0012050646.USD","BK4023","MBX","LU0240877869.USD","LU0106261612.USD","LU0240878834.USD"],"gpt_icon":0},{"id":"2488982676","title":"MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2488982676","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488982676?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:00","pubTimestamp":1733144400,"startTime":"0","endTime":"0","summary":"Peer-reviewed publication features positive results from multiple ascending dose (MAD) portion of Phase 1 MBX 2109 study in healthy participantsCARMEL, Ind., Dec.  02, 2024  (GLOBE NEWSWIRE) -- MBX Bi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989746/0/en/MBX-Biosciences-Announces-MBX-2109-Phase-1-Study-Results-Published-in-The-Journal-of-Clinical-Endocrinology-and-Metabolism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","HP","LU1169590202.USD","PTH","BK4181","PD","LU1169589451.USD","BK4007","BK4218","PK","PBH","BK4092","MBX"],"gpt_icon":0},{"id":"2486848048","title":"My Foodie Box Limited Reports Drastic Loss Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2486848048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486848048?lang=en_us&edition=fundamental","pubTime":"2024-11-27 17:10","pubTimestamp":1732698640,"startTime":"0","endTime":"0","summary":"My Foodie Box Limited (AU:MBX) has released an update. My Foodie Box Limited has reported a substantial reduction in net loss for the half-year end...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/my-foodie-box-limited-reports-drastic-loss-reduction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/my-foodie-box-limited-reports-drastic-loss-reduction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","LU0012050646.USD","LU0106261612.USD","BOX","BK4007","LU0240878834.USD","LU0240877869.USD","MBX"],"gpt_icon":0},{"id":"2484627598","title":"MBX Biosciences completes last visit in Phase 1 MBX 1416 trial in hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627598","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484627598?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:20","pubTimestamp":1731936052,"startTime":"0","endTime":"0","summary":"MBX Biosciences (MBX) completed the last subject’s last visit in its Phase 1 single and multiple ascending dose trial of MBX 1416, the company’s lo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-completes-last-visit-in-phase-1-mbx-1416-trial-in-hypoglycemia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-completes-last-visit-in-phase-1-mbx-1416-trial-in-hypoglycemia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2484622483","title":"BRIEF-MBX Biosciences Announces Last Subject Last Visit In Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484622483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484622483?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:12","pubTimestamp":1731935530,"startTime":"0","endTime":"0","summary":"BRIEF-MBX Biosciences Announces Last Subject Last Visit In Phase 1 TrialNov 18 (Reuters) - MBX Biosciences Inc MBX.O:MBX BIOSCIENCES ANNOUNCES LAST SUBJECT LAST VISIT IN PHASE 1 TRIAL OF MBX 1416 FOR ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA9YQHZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2484624708","title":"Mbx Biosciences Announces Last Subject Last Visit in Phase 1 Trial of Mbx 1416 for the Treatment of Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2484624708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484624708?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:00","pubTimestamp":1731934801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA9YQHZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2484622826","title":"Mbx Biosciences :  Look Forward to Sharing Full-Topline Results of Mbx 1416 Program  in Early January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2484622826","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484622826?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:00","pubTimestamp":1731934801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA9YQHZ4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2484622586","title":"MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2484622586","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484622586?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:00","pubTimestamp":1731934800,"startTime":"0","endTime":"0","summary":"Topline results expected in early January 2025CARMEL, Ind., Nov.  18, 2024  (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/18/2982718/0/en/MBX-Biosciences-Announces-Last-Subject-Last-Visit-in-Phase-1-Trial-of-MBX-1416-for-the-Treatment-of-Post-Bariatric-Hypoglycemia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4092","HP","PBH","BK4007","MBX","BK4212","POST"],"gpt_icon":0},{"id":"2482494709","title":"Microbix Enhances HPV Testing with New Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2482494709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482494709?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:57","pubTimestamp":1731416271,"startTime":"0","endTime":"0","summary":"Microbix Biosystms (TSE:MBX) has released an update. Microbix Biosystems has announced successful validation of its HPV Quality Assessment Product ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microbix-enhances-hpv-testing-with-new-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microbix-enhances-hpv-testing-with-new-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2482941014","title":"MBX Biosciences Reports Q3 2024 Financial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2482941014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482941014?lang=en_us&edition=fundamental","pubTime":"2024-11-09 12:29","pubTimestamp":1731126546,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. ( ($MBX) ) has released its Q3 earnings. Here is a breakdown of the information MBX Biosciences, Inc. presented to its invest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-reports-q3-2024-financial-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-reports-q3-2024-financial-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","MBX","BK4097","BK4007","PRGS"],"gpt_icon":0},{"id":"2481043469","title":"MBX Biosciences Q3 EPS $(2.78) Up From $(9.40) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2481043469","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481043469?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:05","pubTimestamp":1730984720,"startTime":"0","endTime":"0","summary":"MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(2.78) per share. This is a 70.43 percent increase over losses of $(9.40) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41805383/mbx-biosciences-q3-eps-2-78-up-from-9-40-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MBX Biosciences Q3 EPS $(2.78) Up From $(9.40) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX"],"gpt_icon":0},{"id":"2481640904","title":"Mbx Biosciences: Q3 Shr Loss $2.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2481640904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481640904?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:00","pubTimestamp":1730984407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA3Z9WCV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2481625904","title":"Mbx Biosciences: Strong Cash Position, With $277.1 Mln Expected to Support Operations Into Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2481625904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481625904?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:00","pubTimestamp":1730984407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA3Z9WCV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBX","BK4007"],"gpt_icon":0},{"id":"2478049141","title":"MBX Biosciences to Participate in Upcoming November Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2478049141","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478049141?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:00","pubTimestamp":1730116800,"startTime":"0","endTime":"0","summary":"CARMEL, Ind., Oct. 28, 2024  -- MBX Biosciences, Inc. , a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that its management team will participate in the following upcoming investor conferences:. Date: Tuesday, November 12, 2024Format: Fireside chatTime: 3:30 p.m. ESTLocation: Boston, MA. Date: Wednesday, November 20, 2024Format: Company presentationTime: 3:30 p.m. GMTLocation: London, UK. About MBX’s Proprietary Precision Endocrine Peptide  Platform MBX was founded by global leaders with a transformative approach to peptide drug design and development. Leveraging this expertise, the Company designed its proprietary Precision Endocrine Peptide  platform to overcome the key limitations of unmodified and modified peptide therapies and to improve clinical outcomes and simplify disease management for patients. PEPs are selectively engineered to hav","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fLwaDndM53MdYDmMBh83xw--~B/aD0zNTU7dz05MDE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5e22010ec212d53a50fbe0c78f89c348","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fLwaDndM53MdYDmMBh83xw--~B/aD0zNTU7dz05MDE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5e22010ec212d53a50fbe0c78f89c348"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mbx-biosciences-participate-upcoming-november-120000322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HP","BK4007","PBH","MBX","BK4092"],"gpt_icon":1},{"id":"2475354910","title":"Opening Day: Another trio of biotech IPOs make Friday debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2475354910","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475354910?lang=en_us&edition=fundamental","pubTime":"2024-10-14 18:45","pubTimestamp":1728902715,"startTime":"0","endTime":"0","summary":"The Partners Group-backed KinderCare sold 24 million shares for $24 each this Tuesday. At the IPO price, the childhood education company had a market value of $2.74B, based on the outstanding shares. Sky Quarry, Click Holdings, and SKK Holdings also opened for trading this week.Meanwhile, a new trio of biotech companies’ shares came to market on Friday as Upstream Bio, Ceribell and Camp4 Therapeutics each made their public debut. In mid-September, Bicara Therapeutics , MBX Biosciences  and Zenas BioPharma  similarly came public on a Friday in their respective initial public offerings.KinderCare Learning  opened on October 9 at $27. The company, which identifies itself as “the nation’s largest private provider of high-quality early childhood education by center capacity,” had priced its initial public offering of 24M shares of its common stock at a public offering price of $24.00 per share. The deal priced inside the $23.00-$27.00 range.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/lBatGXdmW601L3jZUeEVwQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/e1839507ce9d5542b9a5313ac8d70b9e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/lBatGXdmW601L3jZUeEVwQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/e1839507ce9d5542b9a5313ac8d70b9e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/opening-day-another-trio-biotech-104515199.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/opening-day-another-trio-biotech-104515199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0477156953.USD","BK4585","LU0234572021.USD","LU1064131342.USD","LU1261432733.SGD","LU0070302665.USD","LU1363072403.SGD","SKK","LU0203345920.USD","LU0320765489.SGD","BK4207","JPM","LU0128525689.USD","IE00B1BXHZ80.USD","LU0267386448.USD","LU1720051108.HKD","CAMP","BK4504","LU0208291251.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU1267930490.SGD","LU0211331839.USD","BCAX","BK4007","ZBIO","INR","LU1201861249.SGD","LU0203347892.USD","LU0976567544.SGD","LU","KLC","IE00BSNM7G36.USD","MBX","IE00BJTD4N35.SGD","LU0130102774.USD","BK4550","LU0149725797.USD","LU0980610538.SGD","LU0106831901.USD","SKYQ","BK4588","CBLL","LU1074936037.SGD","STFS","LU0310800965.SGD","BK4139","BK4534","LU0496365809.HKD","LU1032466523.USD","UPB","CLIK","C","LU1267930227.SGD","IE00B775SV38.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"MBX","fiscalQuarterEnding":"2024/12","expectedEps":-0.59,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1744344000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBX","date":"2025-04-16","current":-3.98359,"percent":0.938776,"low":-18.37518,"twenty":-15.461179,"median":-10.33185,"eighty":-5.826049,"high":-3.125337,"avg":-10.160551,"sd":4.612319,"marketCap":246671857},"quantilePoints":[{"date":"2024-09-13","current":-10.797864,"twenty":-10.55484,"median":-10.190304,"eighty":-9.825767,"marketCap":509659168},{"date":"2024-09-20","current":-15.015591,"twenty":-15.168364,"median":-14.852916,"eighty":-11.560463,"marketCap":708735908},{"date":"2024-09-27","current":-17.32133,"twenty":-16.200444,"median":-15.47886,"eighty":-14.65927,"marketCap":817566764},{"date":"2024-10-04","current":-17.328403,"twenty":-17.001639,"median":-15.960592,"eighty":-14.885451,"marketCap":817900601},{"date":"2024-10-11","current":-16.663558,"twenty":-17.001639,"median":-16.288699,"eighty":-15.053784,"marketCap":786519924},{"date":"2024-10-18","current":-16.380645,"twenty":-17.034173,"median":-16.380645,"eighty":-15.256067,"marketCap":773166445},{"date":"2024-10-25","current":-16.366499,"twenty":-17.022857,"median":-16.518565,"eighty":-15.513518,"marketCap":772498771},{"date":"2024-10-31","current":-15.744091,"twenty":-17.017199,"median":-16.373572,"eighty":-15.206557,"marketCap":743121117},{"date":"2024-11-08","current":-14.04827,"twenty":-16.953543,"median":-16.31699,"eighty":-15.206557,"marketCap":775169467},{"date":"2024-11-15","current":-11.803503,"twenty":-16.939398,"median":-16.175534,"eighty":-14.610859,"marketCap":651305476},{"date":"2024-11-22","current":-9.99876,"twenty":-16.932325,"median":-15.949203,"eighty":-13.860717,"marketCap":551721571},{"date":"2024-11-29","current":-12.318278,"twenty":-16.904034,"median":-15.751164,"eighty":-12.256505,"marketCap":679710282},{"date":"2024-12-06","current":-11.682379,"twenty":-16.817745,"median":-15.461179,"eighty":-11.791391,"marketCap":644621993},{"date":"2024-12-13","current":-12.415177,"twenty":-16.690435,"median":-15.206557,"eighty":-11.939161,"marketCap":685057069},{"date":"2024-12-20","current":-12.275885,"twenty":-16.663558,"median":-14.934254,"eighty":-11.791391,"marketCap":677371062},{"date":"2024-12-27","current":-13.256987,"twenty":-16.659314,"median":-14.421446,"eighty":-11.803503,"marketCap":731507280},{"date":"2025-01-03","current":-11.052536,"twenty":-16.546149,"median":-14.047442,"eighty":-11.706604,"marketCap":609867878},{"date":"2025-01-10","current":-8.787523,"twenty":-16.380645,"median":-13.843492,"eighty":-11.523707,"marketCap":484886735},{"date":"2025-01-17","current":-6.383218,"twenty":-16.377816,"median":-13.75965,"eighty":-11.170026,"marketCap":352219585},{"date":"2025-01-24","current":-7.103904,"twenty":-16.366499,"median":-13.256987,"eighty":-10.797864,"marketCap":391986313},{"date":"2025-01-31","current":-7.049398,"twenty":-16.359427,"median":-13.057133,"eighty":-9.859468,"marketCap":388978745},{"date":"2025-02-07","current":-7.424882,"twenty":-16.31699,"median":-12.415177,"eighty":-8.842029,"marketCap":409697544},{"date":"2025-02-14","current":-5.444509,"twenty":-16.309917,"median":-12.318278,"eighty":-7.473331,"marketCap":300422587},{"date":"2025-02-21","current":-7.164466,"twenty":-16.270309,"median":-12.215323,"eighty":-7.193536,"marketCap":395328054},{"date":"2025-02-28","current":-5.947173,"twenty":-16.124609,"median":-12.009413,"eighty":-6.809573,"marketCap":328159044},{"date":"2025-03-07","current":-6.213645,"twenty":-15.986606,"median":-11.803503,"eighty":-6.598818,"marketCap":342862708},{"date":"2025-03-14","current":-5.226487,"twenty":-15.951481,"median":-11.682379,"eighty":-6.524932,"marketCap":288392317},{"date":"2025-03-21","current":-4.302061,"twenty":-15.898279,"median":-11.549143,"eighty":-6.302065,"marketCap":266392236},{"date":"2025-03-28","current":-3.999783,"twenty":-15.778041,"median":-11.258446,"eighty":-6.213645,"marketCap":247674589},{"date":"2025-04-04","current":-3.43841,"twenty":-15.745506,"median":-11.107042,"eighty":-6.061029,"marketCap":212913243},{"date":"2025-04-11","current":-3.384432,"twenty":-15.517761,"median":-10.797864,"eighty":-5.941117,"marketCap":209570806},{"date":"2025-04-16","current":-3.98359,"twenty":-15.461179,"median":-10.33185,"eighty":-5.826049,"marketCap":246671857}],"updateTime":1744910656093}}}